IWMPD
GEVA

Integrated Wealth Management (Palm Desert)’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Integrated Wealth Management (Palm Desert)’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-200
Closed -$19K – 1561
2015
Q1 		$19K Buy
+200
New +$21.2K 0.01% 592

Integrated Wealth Management (Palm Desert)'s GEVA Position: Q2 2015 in Review

Integrated Wealth Management (Palm Desert) sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 200 shares — an estimated $19K sold.

Integrated Wealth Management (Palm Desert) first reported a position in GEVA in Q1 2015 and held it in 1 quarter. The position peaked at $19K in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Integrated Wealth Management (Palm Desert) reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Integrated Wealth Management (Palm Desert) sold 200 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $19K.
  • Integrated Wealth Management (Palm Desert) first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • Integrated Wealth Management (Palm Desert)'s SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $19K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q2 2015, filed 17 Jul 2015.